162 related articles for article (PubMed ID: 17652097)
1. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies.
Wei J; Fujita M; Nakai M; Waragai M; Watabe K; Akatsu H; Rockenstein E; Masliah E; Hashimoto M
J Biol Chem; 2007 Sep; 282(39):28904-28914. PubMed ID: 17652097
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
3. Dementia with Lewy bodies-associated ß-synuclein mutations V70M and P123H cause mutation-specific neuropathological lesions.
Psol M; Darvas SG; Leite K; Mahajani SU; Bähr M; Kügler S
Hum Mol Genet; 2021 Apr; 30(3-4):247-264. PubMed ID: 33760043
[TBL] [Abstract][Full Text] [Related]
4. Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.
Wei J; Fujita M; Nakai M; Waragai M; Sekigawa A; Sugama S; Takenouchi T; Masliah E; Hashimoto M
Am J Pathol; 2009 May; 174(5):1891-909. PubMed ID: 19349362
[TBL] [Abstract][Full Text] [Related]
5. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Fujita M; Ho G; Takamatsu Y; Wada R; Ikeda K; Hashimoto M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325870
[TBL] [Abstract][Full Text] [Related]
6. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein.
Sekigawa A; Fujita M; Sekiyama K; Takamatsu Y; Hatano T; Rockenstein E; La Spada AR; Masliah E; Hashimoto M
Mol Brain; 2012 Sep; 5():34. PubMed ID: 23013868
[TBL] [Abstract][Full Text] [Related]
7. Effect of Disease-Associated P123H and V70M Mutations on β-Synuclein Fibrillation.
Sharma K; Mehra S; Sawner AS; Markam PS; Panigrahi R; Navalkar A; Chatterjee D; Kumar R; Kadu P; Patel K; Ray S; Kumar A; Maji SK
ACS Chem Neurosci; 2020 Sep; 11(18):2836-2848. PubMed ID: 32833434
[TBL] [Abstract][Full Text] [Related]
8. Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathies.
Fujita M; Sekigawa A; Sekiyama K; Takamatsu Y; Hashimoto M
Int J Mol Sci; 2012; 13(9):11584-11592. PubMed ID: 23109872
[TBL] [Abstract][Full Text] [Related]
9. Beta-synuclein gene alterations in dementia with Lewy bodies.
Ohtake H; Limprasert P; Fan Y; Onodera O; Kakita A; Takahashi H; Bonner LT; Tsuang DW; Murray IV; Lee VM; Trojanowski JQ; Ishikawa A; Idezuka J; Murata M; Toda T; Bird TD; Leverenz JB; Tsuji S; La Spada AR
Neurology; 2004 Sep; 63(5):805-11. PubMed ID: 15365127
[TBL] [Abstract][Full Text] [Related]
10. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
[TBL] [Abstract][Full Text] [Related]
11. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
[TBL] [Abstract][Full Text] [Related]
12. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
13. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
15. The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
Janowska MK; Baum J
Protein Sci; 2016 Jan; 25(1):286-94. PubMed ID: 26332674
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
17. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha-synuclein implies Lewy body biogenesis.
Liu C; Fei E; Jia N; Wang H; Tao R; Iwata A; Nukina N; Zhou J; Wang G
J Biol Chem; 2007 May; 282(19):14558-66. PubMed ID: 17360705
[TBL] [Abstract][Full Text] [Related]
18. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
[TBL] [Abstract][Full Text] [Related]
20. Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies.
Sekigawa A; Takamatsu Y; Sekiyama K; Hashimoto M
Biomolecules; 2015 May; 5(2):1000-11. PubMed ID: 25996784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
